QUALITY & REGULATORY LEADERS SAFEGUARDING BIOPHARMA INNOVATION, 2026
In a healthcare landscape where access remains one of the most urgent challenges of our time, Natalie Conde is redefining what it means to deliver compassionate, high-quality care at scale. Blending frontline clinical expertise with executive oversight of statewide telemedicine platforms, she represents a new generation of healthcare leaders who understand that innovation must always serve humanity.
On Cover
Sharis Hazel
Senior Vice President, Quality, Regulatory Affairs & Operational Excellence
It does not emerge on the front lines of patient care, yet its absence would be felt in every hospital, every clinic, and every pharmacy on earth. It is the leadership of those who build the quality frameworks, regulatory standards, and operational cultures that determine whether life-saving therapies reach patients safely and reliably. Sharis Hazel has spent more than two decades at precisely that intersection, and her career is a study in what principled, purpose-driven leadership looks like when it is sustained across the full arc of a professional life.
Martin Kussmann
PhD, CEO & Founder | Kussmann BioTech
In an era where scientific specialization often narrows focus to molecular minutiae, Martin Kussmann has spent three decades doing precisely the opposite: expanding his vision from proteins to planetary health, from mass spectrometry to meaningful impact, from academic discovery to real-world solutions that feed and heal humanity.
Dr. Jennifer Johnston
Founder & CEO of Elle, MD Biotechnologies
In her clinical practice as a family physician, Dr. Jennifer Johnston observed a recurring theme: women expressing a desire for more contraceptive options that better suited their individual needs and lifestyles. This clinical insight, combined with her perspective as a mother of four children—three daughters—sparked the idea that would eventually become Elle, MD Biotechnologies.
